CA2244997A1 - Administration prolongee d'un agent actif a l'aide d'un systeme implantable - Google Patents

Administration prolongee d'un agent actif a l'aide d'un systeme implantable

Info

Publication number
CA2244997A1
CA2244997A1 CA 2244997 CA2244997A CA2244997A1 CA 2244997 A1 CA2244997 A1 CA 2244997A1 CA 2244997 CA2244997 CA 2244997 CA 2244997 A CA2244997 A CA 2244997A CA 2244997 A1 CA2244997 A1 CA 2244997A1
Authority
CA
Canada
Prior art keywords
active agent
sustained delivery
implantable system
chamber
agent formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2244997
Other languages
English (en)
Other versions
CA2244997C (fr
Inventor
John R. Peery
Keith E. Dionne
Felix A. Landrau
Scott D. Lautenbach
Judy A. Magruder
Jeremy C. Wright
James B. Eckenhoff, (Deceased)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intarcia Therapeutics Inc
Original Assignee
Alza Corporation
John R. Peery
Keith E. Dionne
Felix A. Landrau
Scott D. Lautenbach
Judy A. Magruder
Jeremy C. Wright
James B. Eckenhoff, (Deceased)
Intarcia Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corporation, John R. Peery, Keith E. Dionne, Felix A. Landrau, Scott D. Lautenbach, Judy A. Magruder, Jeremy C. Wright, James B. Eckenhoff, (Deceased), Intarcia Therapeutics, Inc. filed Critical Alza Corporation
Priority to CA002533678A priority Critical patent/CA2533678C/fr
Priority claimed from PCT/US1997/000722 external-priority patent/WO1997027840A1/fr
Publication of CA2244997A1 publication Critical patent/CA2244997A1/fr
Application granted granted Critical
Publication of CA2244997C publication Critical patent/CA2244997C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
CA 2244997 1996-02-02 1997-01-15 Administration prolongee d'un agent actif a l'aide d'un systeme implantable Expired - Lifetime CA2244997C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002533678A CA2533678C (fr) 1996-02-02 1997-01-15 Administration prolongee d'un agent actif a l'aide d'un systeme implantable

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59576196A 1996-02-02 1996-02-02
US08/595,761 1996-02-02
PCT/US1997/000722 WO1997027840A1 (fr) 1996-02-02 1997-01-15 Administration prolongee d'un agent actif a l'aide d'un systeme implantable

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002533678A Division CA2533678C (fr) 1996-02-02 1997-01-15 Administration prolongee d'un agent actif a l'aide d'un systeme implantable

Publications (2)

Publication Number Publication Date
CA2244997A1 true CA2244997A1 (fr) 1997-08-07
CA2244997C CA2244997C (fr) 2007-05-01

Family

ID=29422847

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2244997 Expired - Lifetime CA2244997C (fr) 1996-02-02 1997-01-15 Administration prolongee d'un agent actif a l'aide d'un systeme implantable

Country Status (1)

Country Link
CA (1) CA2244997C (fr)

Also Published As

Publication number Publication date
CA2244997C (fr) 2007-05-01

Similar Documents

Publication Publication Date Title
EP1249229A3 (fr) Libération contrôlée d'un principe actif à l'aide d'un dispositif implantable
ZA912380B (en) Osmotic dosage system for liquid drug delivery
TW347339B (en) Oral delivery of discrete units
CA2289668A1 (fr) Configurations de reglage du debit pour dispositif d'administration d'agent actif
CA2416383A1 (fr) Feuille contenant des produits dermatologiques
AU6136199A (en) Dosage form comprising therapeutic formulation
GR900100104A (en) Intravenal system for the beneficient agent release
GB2341550A (en) Gastroretentive controlled release microspheres for improved drug delivery
ES8602388A1 (es) Un sistema distribuidor para distribuir una formulacion de agente beneficioso al entorno de uso
WO2001043749A3 (fr) Implant pharmacologique contenant des composants a liberation immediate et a liberation prolongee et procede d'administration
CA2377150A1 (fr) Appareil de distribution de produit pesticide du type "appat et substitution"
AU6740687A (en) Pseudoephedrine, brompheniramin therapy
WO1997037640A3 (fr) Traitement par administration uniforme de medicaments
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
CA2533678A1 (fr) Administration prolongee d'un agent actif a l'aide d'un systeme implantable
CA2244997A1 (fr) Administration prolongee d'un agent actif a l'aide d'un systeme implantable
CA2356306A1 (fr) Phosphatidylinositols sulfates, leur preparation et utilisation
GR900100162A (en) System for intravenal release of a beneficial agent
NO307125B1 (no) Peroralt leveringssystem for legemidler
AU5883196A (en) Osmotic device with delayed activation of drug delivery and omplete drug release
CA2220301A1 (fr) Dispositif osmotique avec activation retardee de l'apport d'un medicament et liberation complete du medicament
IL156090A0 (en) Sustained delivery of an active agent using an implantable system

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170116